Cancer Detection and Diagnosis Research in Georgia
Cancer Detection and Diagnosis Research (93.394) awarded $42.2 million to recipients in Georgia in 31 grants from fiscal 2021 to 2025, 1.6% of the program's national total. Emory University received the most, $24.1 million.
- Awarded in Georgia$42.2 million
- Awards31
- Share of the program1.6%
- Rank among states18th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 16 | $6.4 million |
| FY 2022 | 17 | $8.2 million |
| FY 2023 | 18 | $8.7 million |
| FY 2024 | 18 | $9.3 million |
| FY 2025 | 18 | $9.7 million |
Recipients in Georgia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Emory University | Colleges and universities | 17 | $24.1 million |
| Georgia Tech Research Corp | Colleges and universities | 8 | $10.0 million |
| Exvade Bioscience Inc | Small businesses | 1 | $2.4 million |
| University of Georgia Research Foundation, Inc. | Nonprofits | 1 | $2.1 million |
| Inlighta Biosciences L.L.C. | Small businesses | 1 | $2.0 million |
| Augusta University Research Institute, Inc | Nonprofits | 1 | $890,810 |
| Sanicka, Inc | Small businesses | 1 | $396,908 |
| Georgia State University Research Foundation Inc | Colleges and universities | 1 | $277,226 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Georgia?
$42.2 million from fiscal 2021 to 2025, across 31 awards. Georgia ranks 18th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Georgia?
The largest recipient is Emory University, with $24.1 million in 17 awards. Next are Georgia Tech Research Corp and Exvade Bioscience Inc.
Can organizations in Georgia apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Georgia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- 1332 State Innovation Waivers
- Children's Health Insurance Program
- Special Education Grants to States
- Temporary Assistance for Needy Families